Method for increasing viridiflorol content in tissues

US12018264B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12018264-B2
Application numberUS-202117226283-A
CountryUS
Kind codeB2
Filing dateApr 9, 2021
Priority dateJun 24, 2020
Publication dateJun 25, 2024
Grant dateJun 25, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to the development of high viridiflorol containing variety for enhancing the aroma as well as medicinal properties of Mentha piperita by overexpressing MPTPS4 gene through genetic transformation. This transgenic plant possesses better growth and able to produce essential oil with good quality contains high viridiflorol maximum of about 25% and proportionate decrease in menthone, menthofuran and menthol of Mentha piperita as compared to other control genotype. Mentha piperita (CIM-madhuras) that produces viridiflorol, a molecule of potential demand in perfumery, cosmetics, toiletries, drugs and sanitation products.

First claim

Opening claim text (preview).

We claim: 1. A method for expressing increasing viridiflorol content in Lamiaceae plant tissues, said method comprising the following steps: a) isolating the MPTS4 gene of SEQ ID NO:4 from Mentha piperita; b) cloning the MPTPS4 gene obtained at step (a) into a pHANNIBAL vector to generate the cassette of SEQ ID NO:8; c) re-cloning the cassette obtained at step (b) into a pART27 binary vector system to obtain a vector comprising SEQ ID NO:9; and d) transforming the vector obtained at step (c) into Agrobacterium tumefaciens , then further transfecting it into Lamiaceae plant tissues to produce Lamiaceae plant tissues exhibiting increased viridiflorol content compared to Lamiaceae plant tissues that are transfected with a control pART27 binary vector system that does not comprise the cassette of SEQ ID NO:8. 2. A transgenic plant tissue prepared by the method according to claim 1 . 3. A composition comprising the transgenic plant tissue according to claim 2 , wherein the composition is a perfumery, a cosmetic, a toiletry, or a drug. 4. A composition comprising the transgenic plant tissue according to claim 2 , wherein the composition is a sanitation product.

Assignees

Inventors

Classifications

  • Lyases (4.) · CPC title

  • involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine · CPC title

  • C11B9/025Primary

    Recovery by solvent extraction · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12018264B2 cover?
The present invention relates to the development of high viridiflorol containing variety for enhancing the aroma as well as medicinal properties of Mentha piperita by overexpressing MPTPS4 gene through genetic transformation. This transgenic plant possesses better growth and able to produce essential oil with good quality contains high viridiflorol maximum of about 25% and proportionate decreas…
Who is the assignee on this patent?
Council Scient Ind Res, Council Scient Ind Res
What technology area does this patent fall under?
Primary CPC classification C12N15/8243. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).